The Cys-Asn-Ser carboxyl-terminal end group is the pharmacophore of the amebic anti-inflammatory monocyte locomotion inhibitory factor (MLIF)

Molecular and Biochemical Parasitology

Volumn 158, Issue 1, 2008, Pages 46-51

  Morales Martínez, María Esther ^a   Silva García, Raúl ^a   Soriano Correa, Catalina ^b   Giménez Scherer, Juan Antonio ^a   Rojas Dotor, Sara ^a   Blanco Favela, Francisco ^a   Rico Rosillo, Guadalupe ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Anti inflammatory pentapeptide; Delayed cutaneous hypersensitivity; MLIF; Respiratory burst

Indexed keywords

CYSTEINYLASPARAGINYLSERINE; GLUTAMINYLCYSTEINYLASPARAGINE; GLUTAMINYLCYSTEINYLMETHIONYLSERYLASPARAGINE; METHIONYLGLUTAMINYLCYSTEINE; METHIONYLGLUTAMINYLCYSTEINYLASPARGINYLSERINE; METHIONYLLYSYLCYSTEINYLASPARAGINYLSERINE; MONOCYTE LOCOMOTION INHIBITORY FACTOR; NITROBENZENE DERIVATIVE; OLIGOPEPTIDE; TRIPEPTIDE; UNCLASSIFIED DRUG;

AB INITIO CALCULATION; AMOEBA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOASSAY; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; DENSITY FUNCTIONAL THEORY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHAGOCYTE; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN STRUCTURE; RESPIRATORY BURST; SKIN ALLERGY;

ANIMALS; CELLS, CULTURED; ENTAMOEBA HISTOLYTICA; GUINEA PIGS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOLOGIC FACTORS; MALE; MODELS, MOLECULAR; OLIGOPEPTIDES; RESPIRATORY BURST;

ENTAMOEBA HISTOLYTICA;

EID: 38649094298     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2007.11.010     Document Type: Article

References (17)

1. WHO. The world health report 1995-bridging the gaps. World Health Forum 16 (1995) 377-385
2. Pérez-Tamayo R. Pathology of amebiasis. In: Palomo M. (Ed). Amebiasis (1986), Elsevier, Amsterdam 45
3. Kretschmer R., Collado M.L., Pacheco M.G., et al. Inhibition of human monocytes locomotion by products of axenically grown Entamoeba histolytica. Parasite Immunol 7 (1985) 527-543
4. Kretschmer R., Rico G., and Giménez-Scherer J.A. A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica. Mol Biochem Parasitol 112 2 (2001) 201-209
5. The Sanger Institute Research. http://www.sanger.ac.uk.
6. Rico G., Díaz-Guerra O., Giménez-Scherer J.A., and Kretschmer R. Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes. Arch Med Res 23 2 (1992) 157-159
7. Rico G., Leandro E., Rojas S., Giménez-Scherer J.A., and Kretschmer R. The monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes. Parasitol Res 90 (2003) 264-267
8. Rico G., Arellano J., and Kretschmer R. The human monocyte locomotion inhibitory factor produced by Entamoeba histolytica does not inhibit the locomotion of human eosinophils. Parasitol Res 84 (1998) 522-523
9. Giménez-Scherer J.A., Rico G., Fernández-Díez J., and Kretschmer R. Inhibition of contact cutaneous delayed hypersensitivity reaction to DNCB in guinea pigs by the monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica. Arch Med Res 28 (1997) 237-238
10. Giménez-Scherer J.A., Arenas E., Díaz L., Rico G., Fernández-Díez J., and Kretschmer R. Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica on the expression of cell adhesion molecules (CAMs) in the skin of guinea pigs. Arch Med Res 31 (2000) 92-93
11. Sepúlveda B., and Martínez-Palomo A. Immunology of amebiasis by Entamoeba histolytica. In: Cohen S., and Warren K.S. (Eds). Immunology of parasitic diseases (1982), Blackwell Scientific Publications, Oxford 170-191
12. Soriano-Correa C., Sánchez-Ruiz J.F., Rico-Rosillo G., Giménez-Scherer J.A., Velázquez-Rodríguez J., and Kretschmer-Schmid R. Electronic structure and physicochemical properties of the anti-inflammatory pentapeptide produced by Entamoeba histolytica: a theoretical study. J Mol Struct Theochem 769 (2006) 91-95
13. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 21 97 (1968) 77-109
14. Armitage P., Berry G., and Matthews J.N.S. Statistical methods in medical research. 4th ed. (2002), Blackwell Scientific Publications, Oxford pp. 277-89
15. Pinilla C., Appel J.R., and Houghten R.A. Synthetic peptide libraries for research and drug discovery. In: Zegers D.N., Boersna J.A.W., and Claassen E. (Eds). Immunological recognition of peptides in medicine and biology (1995), CRC Press, Inc., Boca Ratón 1-14
16. Carter B.Z., Gronda M., Wang Z., et al. Small-molecule XIAP inhibitors derepreess downstream effector caspases and induce apoptosis of acute myeloid leukemia cells. Blood 105 10 (2005) 4043-4050
17. Giménez-Scherer J.A., Cárdenas G., López-Osuna M., et al. Immunization with a tetramer derivative of an anti-inflammatory pentapeptide produced by E. histolytica protecs gerbils (Meriones unguiculatus) against experimental amoebic abscess of the liver. Parasite Immunol 26 (2004) 343-349